Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology, called the Pipeline Embolization Device (PED), gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms with the use of minimally invasive techniques.
The treatment is focused on reconstruction or remodeling of the weak blood vessel harboring the brain aneurysm.
The Pipeline Device may offer improved patient results with a safe and effective treatment of large or giant, wide-necked aneurysms, which until now has been an unmet clinical need,” said Dr. Demetrius Lopes, neuroendovascular surgeon at Rush University Medical Center. “We are able to help people who did not have a better option and would otherwise die without treatment.”
Rush is the only hospital in Illinois and one of only seven medical centers in the U.S. with the ability to offer treatment with PED, and was one of only a handful of centers in the U.S. that participated in the initial FDA clinical trials.
It is estimated that one in 50 Americans have a brain aneurysm, an abnormal ballooning of a portion of an artery in the brain due to a weakened blood vessel wall.
Read the entire news release.